BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15035421)

  • 1. [Homeopathy suppresses COX- and LOX activity. Soft therapy for arthrosis ills].
    MMW Fortschr Med; 2004 Jan; 146(5):47. PubMed ID: 15035421
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
    Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP;
    J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective COX 2 inhibitor rofecoxib. To "defy" the pain].
    MMW Fortschr Med; 2003 Aug; 145(31-32):56-7. PubMed ID: 14524083
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the demonstration of adenoma reduction with rofecoxib a pyrrhic victory?
    Lynch PM
    Gastroenterology; 2006 Dec; 131(6):2003-5. PubMed ID: 17188962
    [No Abstract]   [Full Text] [Related]  

  • 5. Why don't we initiate more large simple randomized controlled trials?
    Wright JM
    CMAJ; 2003 Nov; 169(11):1170-1. PubMed ID: 14638653
    [No Abstract]   [Full Text] [Related]  

  • 6. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of the education of a patient with arthrosis].
    Ravaud P
    Rev Prat; 2002 Mar; 52(5 Suppl):S21-2. PubMed ID: 11949494
    [No Abstract]   [Full Text] [Related]  

  • 8. Pain relief at a price. A blow to the heart?
    Comarow A
    US News World Rep; 2001 Sep; 131(8):45. PubMed ID: 11550395
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical inquiries. Do COX-2 inhibitors worsen renal function?
    Wall R; Strickland C; Jamieson B; Lo V
    J Fam Pract; 2007 Nov; 56(11):957-8. PubMed ID: 17976347
    [No Abstract]   [Full Text] [Related]  

  • 10. [Meta-analysis on acute pain. Rofecoxib helped three quarters of patients].
    MMW Fortschr Med; 2003 Aug; 145(31-32):57. PubMed ID: 14524084
    [No Abstract]   [Full Text] [Related]  

  • 11. Use and misuse of the p-value.
    Lesaffre E
    Bull NYU Hosp Jt Dis; 2008; 66(2):146-9. PubMed ID: 18537787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials. Nail-biting time for trials of COX-2 drugs.
    Couzin J
    Science; 2004 Dec; 306(5702):1673-5. PubMed ID: 15576585
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.
    Spalding WM; Reeves MJ; Whelton A
    Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
    Vanchieri C
    J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
    [No Abstract]   [Full Text] [Related]  

  • 16. EULAR recommendations for the management of knee osteoarthritis.
    Jawad AS
    Ann Rheum Dis; 2001 May; 60(5):540. PubMed ID: 11345080
    [No Abstract]   [Full Text] [Related]  

  • 17. Decisions loom on selective COX-2 inhibitors.
    Miller JL
    Am J Health Syst Pharm; 1999 Jan; 56(2):106-7. PubMed ID: 10030522
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
    Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention of post-surgical neuralgia.
    Reuben SS
    Pain; 2005 Jan; 113(1-2):242-3; author reply 243-4. PubMed ID: 15621388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.